Randall E. Morris
8Patents
6h-index
4Co-inventors
48Inventor score
Filing activity: Mar 3, 1987 → May 26, 1995
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5516781A | Method of treating restenosis with rapamycin | Human Necessities | 257 | Expired |
| US5563146A | Method of treating hyperproliferative vascular disease | Human Necessities | 160 | Expired |
| US5283257A | Method of treating hyperproliferative vascular disease | Human Necessities | 120 | Expired |
| US5646160A | Method of treating hyperproliferative vascular disease with rapamycin and mycophenolic acid | Human Necessities | 117 | Expired |
| US5665728A | Method of treating hyperproliferative vascular disease | Human Necessities | 98 | Expired |
| US5519042A | Method of treating hyperproliferative vascular disease | Human Necessities | 40 | Expired |
| US4889842A | Concanavalin A dimers as therapeutic agents | Human Necessities | 5 | Expired |
| US5571800A | Method for inhibiting allograft rejection by the administration of 6-azauridine or its triacetate derivative | Human Necessities | 5 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.